Signant Health Unveils its full Conference Line-up for SCOPE 2020

February 11, 2020 Heather Bilinski

Subject matter experts, technologists, scientists and executives to advance patient-centric conversations with innovative clinical operations leaders from global pharmaceutical companies

PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient-centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research.

Join the conversation at SCOPE with these engaging sessions:

Keynote Panel - Taking the Plunge: Why Now is the Time to Invest in eConsent and Patient Engagement

Moderated by Bill Byrom, MD | VP, Product Strategy and Innovation

Featuring panellists Michelle Shogren (Bayer Pharmaceuticals), Hassan Kadhim (Bristol Myers-Squibb), Kelly McKee (Vertex Pharmaceuticals) and Gretchen Goller (ICON plc)
Tuesday, February 18 at 5:05pm


Mobile Sensors in Clinical Trials and Evidentiary Considerations for Electronic Submissions

Presented by Dr. Byrom

Wednesday, February 19 at 10:55am


Using Advanced Risk-Based Monitoring Models to Improve Endpoint Quality

Presented by Todd Everhart, MD | Clinical Vice President, Internal Medicine

Wednesday, February 19 at 12:50pm


Navigating the Patient Journey: A Responsibility All Technology Providers Share

Presented by Mike Nolte | CEO

Thursday, February 20 at 7:45am


Novel Digital Endpoints in Clinical Research: Technology, Infrastructure, Relationship with Technology Providers

Moderated by Michelle Crouthamel (AbbVie)

Featuring panellists Mike Nolte, Jeremy Wyatt (Actigraph), Jennifer Goldsack (DiMe) and Sina Djali (Johnson & Johnson)
Thursday, February 20 at 11:45am


Enable Empowered Patients in Clinical Trials By Integrating the Patient’s Voice, Health Literacy and Cultural Sensitivity

Sessions chaired by Chris Crucitti | Chief Commercial Officer

Thursday, February 20 at 4:10pm

Visitors to the Signant Health exhibit booth will have the opportunity to meet with subject matter experts, technologists and scientists and go hands-on with the latest patient-centric technologies including eCOA, sensors and wearables, eConsent, patient engagement, IRT and more.

Mike Nolte, CEO of Signant Health said, “Many of our partners and colleagues see opportunities to transform clinical research through the eyes of the patient. For us, this is deeply personal, and the beauty of SCOPE is that it brings together all of the people who are in the position – and who have the passion – to make that change a reality. SCOPE is a unique gathering because it links great leaders to great thinking that spans the tactical and strategic. We are proud to get the opportunity to collaborate and share with partners and colleagues across so many critical themes and challenges within clinical research."

About the Author

Heather Bilinski

Associate Director of Marketing at Signant Health

More Content by Heather Bilinski
Previous Video
Get to Know TrialConsent - Signant Health
Get to Know TrialConsent - Signant Health

TrialConsent offers a collaborative platform for developing and updating consent documentation and a real-t...

Next Article
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey

Signant Health released the findings from its latest “State of eConsent” report, highlighting the sentiment...